Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pediatrix Medical (MD) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to 13.81%.

  • Pediatrix Medical's EBIT Margin rose 71900.0% to 13.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.37%, marking a year-over-year increase of 213000.0%. This contributed to the annual value of 3.41% for FY2024, which is 37800.0% down from last year.
  • Per Pediatrix Medical's latest filing, its EBIT Margin stood at 13.81% for Q3 2025, which was up 71900.0% from 12.77% recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's EBIT Margin ranged from a high of 13.81% in Q3 2025 and a low of 31.28% during Q2 2024
  • Its 5-year average for EBIT Margin is 5.18%, with a median of 7.95% in 2023.
  • As far as peak fluctuations go, Pediatrix Medical's EBIT Margin plummeted by -409600bps in 2024, and later skyrocketed by 440400bps in 2025.
  • Over the past 5 years, Pediatrix Medical's EBIT Margin (Quarter) stood at 13.64% in 2021, then plummeted by -49bps to 7.01% in 2022, then plummeted by -420bps to 22.46% in 2023, then skyrocketed by 135bps to 7.82% in 2024, then skyrocketed by 77bps to 13.81% in 2025.
  • Its EBIT Margin stands at 13.81% for Q3 2025, versus 12.77% for Q2 2025 and 7.0% for Q1 2025.